Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
VIS410
DRUG
2 trials
Sponsors
Visterra, Inc.
Conditions
Influenza
Phase 1
A Study of VIS410 to Assess Safety and Pharmacokinetics
Completed
NCT02045472
Visterra, Inc.
Influenza
Start: 2014-09-30
End: 2015-05-31
Updated: 2015-05-14
Phase 2
Influenza Challenge Study of VIS410 in Healthy Volunteers
Completed
NCT02468115
Visterra, Inc.
Influenza
Start: 2015-05-31
End: 2016-02-29
Updated: 2016-04-05
Related Papers
Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study
Antiviral Research
2020-03-06
27 citations
Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks.
2016-02-26
44 citations